journal article·2022-02

Synthesis and Characterization of a Ti–Zr‐Based Alloy with Ultralow Young's Modulus and Excellent Biocompatibility

Kyong Min Kim, Yazan Al-Zain, Akiko Yamamoto, Amirah H. Daher, Ahmad T. Mansour, Jihad M. AlAjlouni, Abdelkarim S. Aloweidi, Mousa A. Al-Abbadi, Hee Young Kim, Shuichi Miyazaki

Advanced Engineering Materials· Volume 24· Issue 2
Publisher page

Abstract

Recently, metastable β‐type Ti alloys have attracted attention as promising materials for medical implants due to low Young's modulus and superior biocompatibility. The former is dependent on texture developed during the thermomechanical process. Herein, new Ti–Zr–Nb–Sn–Mo alloys with ultralow Young's modulus and excellent biocompatibility are developed as promising materials for medical implants. The effect of Mo on the microstructure and mechanical properties of the Ti–18Zr–5Nb–3Sn system is investigated. X‐ray diffraction (XRD) and scanning electron microscope (SEM) results reveal that Mo acts as a β‐phase stabilizer. Moreover, mechanical behavior and recrystallization texture show strong composition dependence; the 2.5Mo alloy shows the lowest Young's modulus of 40 GPa. This is due to the formation of a recrystallization texture with strong Goss component of <001>. Corrosion behavior of the 2.5Mo alloy in the cell culture medium is similar to that of the commercially pure titanium (cp‐Ti), suggesting excellent corrosion resistance in the biological environment. Both murine fibroblasts and osteoblastic cells show good growth on the 2.5Mo alloy as the same level of that on the cp‐Ti. Implantation into rat subcutaneous tissue confirms no significant difference in the tissue reaction between the 2.5Mo alloy and the cp‐Ti.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Titanium Alloys Microstructure and Properties · Orthopaedic implants and arthroplasty · Advanced materials and composites

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Metal Materials Division Korea Institute of Materials Science Changwon 51508 Republic of Korea

Faculty of Pure and Applied Sciences University of Tsukuba Tsukuba Ibaraki 305-8573 Japan

Department of Industrial Engineering The University of Jordan Amman 11942 Jordan

Research Center for Functional Materials National Institute for Materials Science Tsukuba Ibaraki 305-0044 Japan

Department of Pediatrics School of Medicine University of Jordan Amman 11942 Jordan

Department of Pathology Microbiology and Forensic Medicine School of Medicine University of Jordan Amman 11942 Jordan

Department of Pathology and Laboratory Medicine University of Cincinnati-School of Medicine Cincinnati OH USA

Department of Orthopedics School of Medicine University of Jordan Amman 11942 Jordan

Department of Anesthesia and Intensive Care School of Medicine University of Jordan Amman 11942 Jordan

References (63)

Show source-provided references
1. 10.1016/S0010-938X(03)00148-310.1016/S0010-938X(03)00148-3 ↗
2. 10.1520/STP1365-EB10.1520/STP1365-EB ↗
3. 10.1016/j.jmbbm.2007.07.00110.1016/j.jmbbm.2007.07.001 ↗
4. 10.1007/s11837-008-0031-110.1007/s11837-008-0031-1 ↗
5. 10.1016/j.actbio.2012.06.03710.1016/j.actbio.2012.06.037 ↗
6. 10.1016/j.mser.2014.10.00110.1016/j.mser.2014.10.001 ↗
7. 10.1126/science.108195710.1126/science.1081957 ↗
8. 10.1016/j.jmbbm.2010.07.00110.1016/j.jmbbm.2010.07.001 ↗
9. 10.1007/s11661-011-0860-310.1007/s11661-011-0860-3 ↗
10. 10.2320/matertrans.45.111310.2320/matertrans.45.1113 ↗
11. 10.1016/j.actamat.2010.09.00710.1016/j.actamat.2010.09.007 ↗
12. 10.2320/matertrans.46.107010.2320/matertrans.46.1070 ↗
13. 10.1016/j.jallcom.2006.08.26710.1016/j.jallcom.2006.08.267 ↗
14. 10.1016/j.actbio.2011.02.00810.1016/j.actbio.2011.02.008 ↗
15. 10.1016/j.jmbbm.2015.12.03710.1016/j.jmbbm.2015.12.037 ↗
16. 10.1016/j.scriptamat.2012.03.02010.1016/j.scriptamat.2012.03.020 ↗
17. 10.1016/j.msea.2016.07.06910.1016/j.msea.2016.07.069 ↗
18. 10.1016/j.msec.2015.01.06110.1016/j.msec.2015.01.061 ↗
19. 10.1016/j.actbio.2015.03.02310.1016/j.actbio.2015.03.023 ↗
20. 10.1016/j.jmbbm.2019.07.01410.1016/j.jmbbm.2019.07.014 ↗
21. 10.1016/j.jallcom.2011.12.15710.1016/j.jallcom.2011.12.157 ↗
22. 10.1088/1748-6041/5/4/04500610.1088/1748-6041/5/4/045006 ↗
23. 10.1016/j.msec.2014.06.01010.1016/j.msec.2014.06.010 ↗
24. 10.1016/j.msea.2006.09.05110.1016/j.msea.2006.09.051 ↗
25. 10.1016/j.actbio.2006.11.00210.1016/j.actbio.2006.11.002 ↗
26. 10.3390/ma1302047610.3390/ma13020476 ↗
27. 10.1016/j.actamat.2010.04.01310.1016/j.actamat.2010.04.013 ↗
28. 10.2320/matertrans.43.297810.2320/matertrans.43.2978 ↗
29. 10.1016/j.biomaterials.2007.12.01110.1016/j.biomaterials.2007.12.011 ↗
30. 10.1016/S0142-9612(00)00221-010.1016/S0142-9612(00)00221-0 ↗
31. 10.1016/j.msec.2019.10990610.1016/j.msec.2019.109906 ↗
32. 10.1016/j.actbio.2015.02.00110.1016/j.actbio.2015.02.001 ↗
33. 10.1016/j.msec.2015.02.00410.1016/j.msec.2015.02.004 ↗
34. ISO 10993-5:2009Biological Evaluation of Medical Devices—Part 5: Tests for In Vitro Cytotoxicity 2009.
35. 10.4028/www.scientific.net/KEM.284-286.80710.4028/www.scientific.net/KEM.284-286.807 ↗
36. 10.2320/matertrans.48.35210.2320/matertrans.48.352 ↗
37. ISO 10993-2 Biological Evaluation of Medical Devices—Part 2: Animal Welfare Requirements 2006.
38. 10.2320/matertrans.45.244310.2320/matertrans.45.2443 ↗
39. Kim H. Y. · 2018
40. 10.1016/j.matdes.2010.11.04910.1016/j.matdes.2010.11.049 ↗
41. 10.1016/j.jmrt.2019.12.06210.1016/j.jmrt.2019.12.062 ↗
42. 10.1016/j.msea.2006.06.01310.1016/j.msea.2006.06.013 ↗
43. 10.1590/S1516-1439200500040001310.1590/S1516-14392005000400013 ↗
44. 10.1016/j.msec.2006.04.00810.1016/j.msec.2006.04.008 ↗
45. 10.1016/j.msea.2011.02.07110.1016/j.msea.2011.02.071 ↗
46. 10.1016/j.msea.2012.06.00910.1016/j.msea.2012.06.009 ↗
47. 10.1016/j.actamat.2013.07.01910.1016/j.actamat.2013.07.019 ↗
48. 10.1016/j.actamat.2013.10.04810.1016/j.actamat.2013.10.048 ↗
49. 10.1016/j.scriptamat.2015.11.02010.1016/j.scriptamat.2015.11.020 ↗
50. 10.1016/j.actamat.2019.11.00910.1016/j.actamat.2019.11.009 ↗
51. 10.1016/j.mtla.2019.10038210.1016/j.mtla.2019.100382 ↗
52. 10.1016/j.actamat.2018.04.03510.1016/j.actamat.2018.04.035 ↗
53. 10.1016/j.actamat.2008.02.01710.1016/j.actamat.2008.02.017 ↗
54. 10.1016/j.msea.2017.02.03110.1016/j.msea.2017.02.031 ↗
55. Freitas R. A. · 1999
56. 10.1063/1.499986610.1063/1.4999866 ↗
57. 10.2320/matertrans.48.36110.2320/matertrans.48.361 ↗
58. 10.2320/matertrans.46.226010.2320/matertrans.46.2260 ↗
59. 10.1016/j.biomaterials.2005.02.02910.1016/j.biomaterials.2005.02.029 ↗
60. Loginov A. G. · Morfologiia · 2003 · 123 · 57
61. 10.1679/aohc.67.21110.1679/aohc.67.211 ↗
62. Krystel-Whittemore M. · Front. Immunol. · 2006 · 6 · 620
63. 10.1080/0167683080258196810.1080/01676830802581968 ↗